FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378078330> ?p ?o ?g. }

• W4378078330 endingPage "18" @default.
• W4378078330 startingPage "1" @default.
• W4378078330 abstract "Angiogenesis is crucial to the development of cancer because it allows the transport of oxygen, nutrients, and growth factors as well as the spread of tumors to distant organs. Inhibitors of angiogenesis prevent the formation of blood vessels that allow tumor cells to shrink, rather than promote tumor growth. Chitosan acts as a carrier for many drugs, since the compound has various properties such as biodegradable, less toxicity, more stable, simple, easy to prepare, and biocompatible. The aim of the current study was to evaluate the efficacy of chitosan nanoparticles encapsulated with troxerutin (Chi-Trox NPs) against angiogenesis and cancer in ova chick chorioallantoic membrane (CAM) model. Chi-Trox NPs were synthesized using a nanoprecipitation method and were characterized by various analyses. 24 hours' fertilized eggs (6 eggs/group) were treated with native Trox and Chi-Trox NPs for 5 days. The antiangiogenic activity was evaluated by morphometric, histopathological, immunohistochemical (CD104 and vimentin), and mRNA expression of MMP and FGF2 using RT-PCR. The anticancer activity was evaluated by histopathological, immunohistochmical (CD44), and mRNA expression of FGF2 and MMP. The synthesized chitosan NPs were successfully encapsulated with troxerutin, and the loading efficiency of chitosan NPs was found to be 86.4 ± 0.12% and 13.2 ± 0.16% respectively. Morphometric analysis of Chi-Trox NPs showed a considerable decrease in the number of blood vessels compared with control and native Trox. The histopathological observation of CAM confirmed that Chi-Trox NPs induce a significant reduction in inflammatory cells and the thickness of blood capillaries compared to control and native Trox. The immunohistochemical evaluation of CAM revealed Chi-Trox decreased CD104, vimentin and CD44 protein levels were compared with control and native Trox. Furthermore, the mRNA expression levels of FGF2 and MMP were significantly downregulated compared to their native forms. From the obtained results, Chi-Trox NPs possess significant inhibition of angiogenesis and can be used as therapeutic agents for cancer in the future." @default.
• W4378078330 created "2023-05-25" @default.
• W4378078330 creator A5025146197 @default.
• W4378078330 creator A5031918830 @default.
• W4378078330 creator A5033538574 @default.
• W4378078330 creator A5041158217 @default.
• W4378078330 creator A5053246879 @default.
• W4378078330 creator A5053771592 @default.
• W4378078330 creator A5067213142 @default.
• W4378078330 creator A5071199153 @default.
• W4378078330 date "2023-05-23" @default.
• W4378078330 modified "2023-09-25" @default.
• W4378078330 title "Antiangiogenic Potential of Troxerutin and Chitosan Loaded Troxerutin on Chorioallantoic Membrane Model" @default.
• W4378078330 cites W1975732260 @default.
• W4378078330 cites W1986191025 @default.
• W4378078330 cites W1998271063 @default.
• W4378078330 cites W2009071437 @default.
• W4378078330 cites W2016091072 @default.
• W4378078330 cites W2055043387 @default.
• W4378078330 cites W2056962182 @default.
• W4378078330 cites W2066932106 @default.
• W4378078330 cites W2067670322 @default.
• W4378078330 cites W2073607907 @default.
• W4378078330 cites W2080876451 @default.
• W4378078330 cites W2085165694 @default.
• W4378078330 cites W2115428779 @default.
• W4378078330 cites W2131798870 @default.
• W4378078330 cites W2163546475 @default.
• W4378078330 cites W2171064149 @default.
• W4378078330 cites W2173771166 @default.
• W4378078330 cites W2254958114 @default.
• W4378078330 cites W2295461409 @default.
• W4378078330 cites W2432199735 @default.
• W4378078330 cites W2555629180 @default.
• W4378078330 cites W2565383127 @default.
• W4378078330 cites W2685809528 @default.
• W4378078330 cites W2705078637 @default.
• W4378078330 cites W2754094845 @default.
• W4378078330 cites W2761830953 @default.
• W4378078330 cites W2762985877 @default.
• W4378078330 cites W2802188549 @default.
• W4378078330 cites W2805037438 @default.
• W4378078330 cites W2909246894 @default.
• W4378078330 cites W2955708813 @default.
• W4378078330 cites W2974469968 @default.
• W4378078330 cites W3009709101 @default.
• W4378078330 cites W3010934686 @default.
• W4378078330 cites W3015202480 @default.
• W4378078330 cites W3036181229 @default.
• W4378078330 cites W3038464575 @default.
• W4378078330 cites W3047565560 @default.
• W4378078330 cites W3139913401 @default.
• W4378078330 cites W3160453648 @default.
• W4378078330 cites W3173401896 @default.
• W4378078330 cites W3176866108 @default.
• W4378078330 cites W3194344650 @default.
• W4378078330 cites W4223889796 @default.
• W4378078330 cites W4244736178 @default.
• W4378078330 cites W4281288373 @default.
• W4378078330 doi "https://doi.org/10.1155/2023/5956154" @default.
• W4378078330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37260851" @default.
• W4378078330 hasPublicationYear "2023" @default.
• W4378078330 type Work @default.
• W4378078330 citedByCount "1" @default.
• W4378078330 countsByYear W43780783302023 @default.
• W4378078330 crossrefType "journal-article" @default.
• W4378078330 hasAuthorship W4378078330A5025146197 @default.
• W4378078330 hasAuthorship W4378078330A5031918830 @default.
• W4378078330 hasAuthorship W4378078330A5033538574 @default.
• W4378078330 hasAuthorship W4378078330A5041158217 @default.
• W4378078330 hasAuthorship W4378078330A5053246879 @default.
• W4378078330 hasAuthorship W4378078330A5053771592 @default.
• W4378078330 hasAuthorship W4378078330A5067213142 @default.
• W4378078330 hasAuthorship W4378078330A5071199153 @default.
• W4378078330 hasBestOaLocation W43780783301 @default.
• W4378078330 hasConcept C109523444 @default.
• W4378078330 hasConcept C142724271 @default.
• W4378078330 hasConcept C147447768 @default.
• W4378078330 hasConcept C185592680 @default.
• W4378078330 hasConcept C204232928 @default.
• W4378078330 hasConcept C2778271429 @default.
• W4378078330 hasConcept C2779732960 @default.
• W4378078330 hasConcept C2780394083 @default.
• W4378078330 hasConcept C502942594 @default.
• W4378078330 hasConcept C55493867 @default.
• W4378078330 hasConcept C71924100 @default.
• W4378078330 hasConcept C86803240 @default.
• W4378078330 hasConcept C97230052 @default.
• W4378078330 hasConcept C98274493 @default.
• W4378078330 hasConceptScore W4378078330C109523444 @default.
• W4378078330 hasConceptScore W4378078330C142724271 @default.
• W4378078330 hasConceptScore W4378078330C147447768 @default.
• W4378078330 hasConceptScore W4378078330C185592680 @default.
• W4378078330 hasConceptScore W4378078330C204232928 @default.
• W4378078330 hasConceptScore W4378078330C2778271429 @default.
• W4378078330 hasConceptScore W4378078330C2779732960 @default.
• W4378078330 hasConceptScore W4378078330C2780394083 @default.
• W4378078330 hasConceptScore W4378078330C502942594 @default.

• next